Gilead Sciences stock nears its all-time high
Why Is Gilead Sciences, Inc. (GILD) Stock Surpassing 9.90% from Its 50-Day SMA?
Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $81.44 which represents a slight increase of $2.27 or 2.87% from the prior close of $79.17. The stock opened at $79.17 and touched a low of $78.
Today, Benzinga's options scanner spotted 9 options trades for Gilead Sciences. This is not a typical pattern. The sentiment ...
Gilead Sciences (GILD ... shows that these estimate changes are directly correlated with near-term stock prices. To capitalize on this, we've crafted the Zacks Rank, a unique model that ...
Although ostensibly an all-cap fund whose investment universe consists of the Russell 3000 Index plus some IPOs and foreign stocks, this has been a mid- and small-cap stock portfolio in practice ...
Leerink Partners analyst Daina Graybosch has maintained their neutral stance on GILD stock, giving a Hold rating on September 12. “Daina ...
Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the ...
Yee notes that while Gilead's stock has not moved much over the last few years, it will likely take off as it moves forward with its new HIV prevention drug. "They have announced this week a ...
J.P. Morgan analyst Chris Schott has maintained their bullish stance on GILD stock, giving a Buy rating on September 13. Chris Schott has ...
In the latest supply deal on the active pharmaceutical ingredients (API) front, Gilead Sciences has tapped South Korea’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback